April Szymanski
Adult Health · Chicago, ILNPI 1942435821
Payments from drug & device makers
Across 16 payments — averaging $34.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$307
- Baxter Healthcare$74
- Argenx US, Inc.$67
- Amylyx Pharmaceuticals, Inc.$40
- Takeda Pharmaceuticals U.S.A., Inc.$26
- Genentech USA, Inc.$25
- plus $21 from 1 others
What the payments were for
- Food & beverage$50390%
- Education$5710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 7 | $307 |
| Baxter Healthcare | 2 | $74 |
| Argenx US, Inc. | 2 | $67 |
| Amylyx Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| AstraZeneca | 1 | $21 |
How this compares
$560 in reported general payments places this provider in the 60th percentile of 553 adult health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 38 | $548,722 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $134,216 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 12 | $51,632 |
| NuedextaDextromethorphan Hbr/Quinidine | 20 | $38,210 |
| Gabapentin | 76 | $1,725 |
| Pyridostigmine Bromide | 17 | $1,557 |
| Riluzole | 14 | $1,503 |
| Baclofen | 39 | $689 |
| Prednisone | 38 | $418 |
| Glycopyrrolate | 11 | $206 |
| Duloxetine Hcl | 11 | $117 |
| Sodium Chloride0.9 % Sodium Chloride | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other adult health in Chicago
- Colleen FolkersChicago$86K
- Matthew BurkeChicago$44K
- Jacklyn GideonChicago$38K
- Jennifer GreenfieldChicago$35K
- Tammy PomaChicago$32K
- Cecille CruzChicago$15K
- Margaret SchwartzChicago$14K
- Karen MeehanChicago$8K
- Michelle EversChicago$8K
- Keriann KordasChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.